DAM
MBOT icon

Diamant Asset Management’s Microbot Medical MBOT Stock Holding History

Diamant Asset Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,000
Closed -$11.2K – 73
2024
Q4 		$11.2K Hold
10,000
– – 0.01% 74
2024
Q3 		$8.94K Hold
10,000
– – 0.01% 75
2024
Q2 		$10.2K Hold
10,000
– – 0.01% 72
2024
Q1 		$12.3K Buy
+10,000
New +$12.7K 0.01% 73

Other funds holding MBOT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Diamant Asset Management's MBOT Position: Q1 2025 in Review

Diamant Asset Management sold out of Microbot Medical (MBOT) in Q1 2025, closing a stake of 10,000 shares — an estimated $11.2K sold.

Diamant Asset Management first reported a position in MBOT in Q1 2024 and held it in 4 quarters. The position peaked at $12.3K in Q1 2024. 43 funds tracked by Wall St. Rank hold MBOT as of Q1 2025.

  • Diamant Asset Management reported no remaining Microbot Medical position as of Q1 2025 after selling out during the quarter.
  • Diamant Asset Management sold 10,000 Microbot Medical shares in Q1 2025, an estimated $11.2K.
  • Diamant Asset Management first reported a position in Microbot Medical in Q1 2024 and held it in 4 quarters.
  • Diamant Asset Management's Microbot Medical position peaked at $12.3K in Q1 2024.
  • 43 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2025.

Based on Diamant Asset Management's 13F filing for Q1 2025, filed 15 May 2025.